Titlebook: ;

即將過時

書目名稱Gastrointestinal Malignancies影響因子(影響力)




書目名稱Gastrointestinal Malignancies影響因子(影響力)學科排名




書目名稱Gastrointestinal Malignancies網絡公開度




書目名稱Gastrointestinal Malignancies網絡公開度學科排名




書目名稱Gastrointestinal Malignancies被引頻次




書目名稱Gastrointestinal Malignancies被引頻次學科排名




書目名稱Gastrointestinal Malignancies年度引用




書目名稱Gastrointestinal Malignancies年度引用學科排名




書目名稱Gastrointestinal Malignancies讀者反饋




書目名稱Gastrointestinal Malignancies讀者反饋學科排名

抵制

labile

樹木心

GLOOM

Hepatocellular Carcinoma: Surgical Management and Evolving Therapies,ing cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250–261, 2020 [.]).

BIAS

Locoregional Therapies for Primary and Secondary Hepatic Malignancies,nt surgeons, and interventional radiologists. Patients should be selected for a specific targeted therapy after multidisciplinary consensus. Interventional oncology, with image-guided locoregional cancer therapies, can decrease systemic toxicity without compromising tumoricidal effect.

BIAS

Gastrointestinal Malignancies978-3-031-61238-1Series ISSN 0927-3042 Series E-ISSN 2509-8497

Fibroid

Sraffa’s Lectures on Continental BankingNeuroendocrine neoplasms are a heterogeneous group of tumors that can occur in almost any organ and share a common neuroendocrine phenotype.

needle

Crohns-disease

https://doi.org/10.1007/978-94-011-9447-1Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and women (Siegel et al. in CA Cancer J Clin 72(1):7–33). Over one-half of newly diagnosed individuals will develop liver metastases. Among those with liver-only metastatic disease, only about one in five will be candidates for potentially curable resection.